产品封面图

FITC标记的磷酸化低密度脂蛋白受体相关蛋白6抗体

收藏
  • ¥2980
  • LMAI Bio
  • LM-5408R-FITC
  • 中国/美国/欧洲
  • 2025年07月13日
  • IF=1:50-200
  • Human, Mouse, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig,
  • Human, Mouse, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig,
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      上海联迈生物工程有限公司

    • 库存

      大量

    • 靶点

      详见说明书

    • 级别

      1

    • 目录编号

      LM-5408R-FITC

    • 克隆性

      多克隆

    • 抗原来源

      Rabbit

    • 保质期

      1年

    • 抗体英文名

      Anti-Phospho-LRP6(Thr1479)/FITC

    • 抗体名

      Anti-Phospho-LRP6(Thr1479)/FITC

    • 标记物

      FITC标记

    • 宿主

      Human, Mouse, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig,

    • 适应物种

      Human, Mouse, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig,

    • 免疫原

      详见说明书

    • 亚型

      IGg

    • 形态

      粉末、液体、冻干粉

    • 应用范围

      IF=1:50-200

    • 浓度

      1mg/ml

    • 保存条件

      -20 °C

    • 规格

      100ul

    FITC标记的磷酸化低密度脂蛋白受体相关蛋白6抗体
    英文名称 Anti-Phospho-LRP6(Thr1479)/FITC
    中文名称 FITC标记的磷酸化低密度脂蛋白受体相关蛋白6抗体
    别    名 LRP6 (Phospho-Thr1479); LRP6 (Phospho-T1479); p-LRP6 (Thr1479); p-LRP6 (T1479); ADCAD2; C030016K15Rik; Cd; FLJ90062; FLJ90421; Low density lipoprotein receptor related protein 6; LRP6_HUMAN; Low-density lipoprotein receptor-related protein 6; low-density lipoprotein receptor-related protein 6 precursor; LRP-6.  
    规格价格 100ul/2980元 购买        大包装/询价
    说 明 书 100ul  
    产品类型 磷酸化抗体 
    研究领域 肿瘤  心血管  免疫学  神经生物学  信号转导  合成与降解  
    抗体来源 Rabbit
    克隆类型 Polyclonal
    交叉反应 Human, Mouse, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig, 
    产品应用 IF=1:50-200  
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量 175kDa
    细胞定位 细胞膜 
    性    状 Lyophilized or Liquid
    浓    度 1mg/ml
    免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human LRP6 around the phosphorylation site of Thr1479
    亚    型 IgG
    纯化方法 affinity purified by Protein A
    储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    产品介绍 background:
    This gene encodes a member of the low density lipoprotein (LDL) receptor gene family. LDL receptors are transmembrane cell surface proteins involved in receptor-mediated endocytosis of lipoprotein and protein ligands. The protein encoded by this gene functions as a receptor or, with Frizzled, a co-receptor for Wnt and thereby transmits the canonical Wnt/beta-catenin signaling cascade. Through its interaction with the Wnt/beta-catenin signaling cascade this gene plays a role in the regulation of cell differentiation, proliferation, and migration and the development of many cancer types. This protein undergoes gamma-secretase dependent RIP- (regulated intramembrane proteolysis) processing but the precise locations of the cleavage sites have not been determined.[provided by RefSeq, Dec 2009].

    Function:
    Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Required for posterior patterning of the epiblast during gastrulation.

    Subunit:
    Homodimer; disulfide-linked. Forms phosphorylated oligomer aggregates on Wnt-signaling. Forms a WNT-signaling complex formed of a WNT protein, a FZD protein and LRP5 or LRP6. Interacts (via the extracellular domain) with WNT1; the interaction is enhanced by prior formation of the Wnt/Fzd complex. Interacts (via the beta-propeller regions 3 and 4) with WNT3A. Interacts (via the beta-propeller regions 1 and 2) with WNT9B. Interacts with FZD5; the interaction forms a coreceptor complex for Wnt signaling and is inhibited by DKK1 and C1orf187. Interacts (via beta propeller regions 3 and 4) with DKK1; the interaction inhibits FZD5/LRP6 complex formation. Interacts with DKK2. Interacts with C1orf187/DRAXIN; the interaction inhibits Wnt signaling. Interacts (via the phosphorylated PPPSP motifs) with AXIN1; the interaction recruits the AXIN1/GSK3B complex to cell surface LRP6 signalsomes. Interacts with GRB10; the interaction prevents AXIN1 binding, thus negatively regulating the Wnt signaling pathway. Interacts (via the extracellular domain) with RSPO1; the interaction activates Wnt/beta-catenin signaling. Interacts (via the extracellular domain) with RSPO3 (via the cysteine rich domain); the interaction activates Wnt/beta-catenin signaling. Interacts (via the beta-propeller regions 1 and 2) with SOST; the interaction competes with DKK1 for binding for inhibiting beta-catenin signaling. Interacts with MESD; the interaction prevents the formation of LRP6 aggregates and targets LRP6 to the plasma membrane. Interacts (via the cytoplasmic domain) with CSNKIE; the interaction phosphorylates LRP6, binds AXIN1 and inhibits AXIN1/GSK3B-mediated phosphorylation of beta-catenin. Interacts with MACF1.

    Subcellular Location:
    Membrane; Single-pass type I membrane protein. Endoplasmic reticulum. Note=On Wnt signaling, undergoes a cycle of caveolin- or clathrin-mediated endocytosis and plasma membrane location. Released from the endoplasmic reticulum on palmitoylation. Mono-ubiquitination retains it in the endoplasmic reticulum in the absence of palmitoylation. On Wnt signaling, phosphorylated, aggregates and colocalizes with AXIN1 and GSK3B at the plasma membrane in LRP6-signalsomes. Chaperoned to the plasma membrane by MESD.

    Tissue Specificity:
    Widely co-expressed with LRP5 during embryogenesis and in adult tissues.

    Post-translational modifications:
    Dual phosphorylation of cytoplasmic PPPSP motifs sequentially by GSK3 and CK1 is required for AXIN1-binding, and subsequent stabilization and activation of beta-catenin via preventing GSK3-mediated phosphorylation of beta-catenin. Phosphorylated, in vitro, by GRK5/6 within and outside the PPPSP motifs. Phosphorylation at Ser-1490 by CDK14 during G2/M phase leads to regulation of the Wnt signaling pathway during the cell cycle. Phosphorylation by GSK3B is induced by RPSO1 binding and inhibited by DKK1. Phosphorylated, in vitro, by casein kinase I on Thr-1479. 
    Undergoes gamma-secretase-dependent regulated intramembrane proteolysis (RIP). The extracellular domain is first released by shedding, and then, through the action of gamma-secretase, the intracellular domain (ICD) is released into the cytoplasm where it is free to bind to GSK3B and to activate canonical Wnt signaling. 
    Palmitoylation on the two sites near the transmembrane domain leads to release of LRP6 from the endoplasmic reticulum. 
    Mono-ubiquitinated which retains LRP6 in the endoplasmic reticulum. 
    N-glycosylation is required for cell surface location.

    DISEASE:
    Defects in LRP6 are the cause of autosomal dominant coronary artery disease type 2 (ADCAD2) [MIM:610947].

    Similarity:
    Belongs to the LDLR family.
    Contains 4 EGF-like domains.
    Contains 3 LDL-receptor class A domains.
    Contains 20 LDL-receptor class B repeats.

    Database links:

    Entrez Gene: 4040 Human

    Entrez Gene: 16974 Mouse

    Omim: 603507 Human

    SwissProt: O75581 Human

    SwissProt: O88572 Mouse

    Unigene: 584775 Human

    Unigene: 658913 Human

    Unigene: 321990 Mouse



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 提高多色流式实验成功的 8 个 Tips

      Tip 1:补偿控制样品必须只染一种颜色 当细胞群同时向两个通道发射荧光时,可能是由于两个原因: 细胞群表达一种 Marker,该标记物被荧光染料偶联的抗体染色,在第二个通道中检测到荧光染料的荧光溢出。 细胞群表达两种 Markers,这些标记物被两种不同荧光染料染色,发射出的荧光到两个通道中。为了在补偿期间排除双阳性细胞的干扰,调节补偿应仅用单一染料染色。 Tip 2:样本中必须包含中位数比较的阴性和阳性细胞群 要正确调节补偿,必须比较溢出通道中阴性和阳性细胞的中位数荧

    • 近 300 万中国患者的帕金森病建模该怎么做?

      度表达或者敲除 PD 相关蛋白(如 α-突触核蛋白或 LRRK2)来转化目标细胞从而达到模拟病理现象的效果。 但是该模型的一个主要缺点是需要超生理水平的表达相关蛋白才能显现出致病性,这与实际病理现象不符。除此之外,该模型中的 α-突触核蛋白聚集体并不是细丝状,这点特征也与实际病理现象不同。   4.活体注射 α-突触核蛋白模型 该模型是将特定条件下制作的活性蛋白聚集体(aSyn PFFs)注射到活体中来模拟 PD 病理现象。 StressMarq 的活性 aSyn PFFs 在结构功能上都与路易小体中的主要

    • 闻一闻就可以减肥?Nat Metab 研究发现食物气味竟能调节脂肪代谢

      ,用正常食物气味进行预刺激会增强油脂摄入诱导的血清甘油三酯水平升高。但禁食期间的食物气味刺激不影响小鼠随后的食物摄入、进食状态下的血糖水平、血清胰岛素或脂联素水平。 代谢笼分析表明禁食期间的气味刺激降低了重新喂食后的呼吸商(RQ)。但在瘦素受体缺陷 db/db 小鼠中,没有检测到 RQ 的这种变化。这些结果表明,用食物气味餐前刺激以瘦素受体相关的方式促进餐后的脂质利用,独立于大脑中的食欲素能和多巴胺能奖励途径。 与减少的呼吸商一致,气味的餐前刺激增加了乳糜微粒和极低密度脂蛋白组分中的血清

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2980
    上海联迈生物工程有限公司
    2025年07月09日询价
    询价
    上海圻明生物科技有限公司
    2025年07月13日询价
    ¥1650
    上海沪震实业有限公司
    2025年03月19日询价
    ¥1280
    北京百奥莱博科技有限公司
    2025年07月15日询价
    ¥1580
    上海钦诚生物科技有限公司
    2025年07月12日询价
    FITC标记的磷酸化低密度脂蛋白受体相关蛋白6抗体
    ¥2980